Global Drug-device Combination Market 2017-2027

LONDON, September 5, 2017 /PRNewswire/ --

Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings

The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 151 page report you will receive 124 charts - all unavailable elsewhere.

The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

• Global Drug-Device Combination Market forecasts from 2017-2027

• Revenue forecast for the drug-device combination market by End-Users:
- Hospitals & clinics
- Emergency service centers
- Ambulatory surgical centers
- Home care settings

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

• Revenue forecast for the drug-device combination market by Products:
- Drug eluting stents
- Photosensitizers
- Orthopaedic products
- Infusion pumps
- Wound care products
- Transmucosal products
- Transdermal patches
- Others

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

• This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
- North America: The U.S and Rest of North America
- Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe
- Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries
- Rest of the world (RoW): Latin America, and Middle East and African countries

Each regional market is further divided by end-users and products

• This report discusses the leading companies in the global drug-device combination market:
- Medtronic
- Boston Scientific Corporation
- Stryker Corporation
- Ethicon Inc
- C.R. Bard Inc.
- Medline Industries Inc.
- Mylan Inc.
- Terumo Corporation
- Pinnacle Biologics Inc.
- W. L. Gore & Associates, Inc.

• This report discusses the drivers, restraints as well as porter's five forces analysis of the global drug-device combination market

Visiongain's study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.

Buy our report today Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/1983/Global-Drug-Device-Combination-Market-2017-2027  

List of Companies and Organizations Mentioned in the Report 

Bayer

Baxter Healthcare

Boehringer Ingelheim

Boston Scientific Corporation

C.R. Bard Inc.

CeloNova Biosciences

Center for Biologics Evaluation and Research (CBER)

Center for Devices and Radiological Health (CDRH)

Center for Drug Evaluation and Research (CDER)

Ethicon Inc

Johnson & Johnson Co.

Meda

Medline Industries Inc.

Medtronic

Menarini Group

Merck KGaA

Mylan Inc.

National Institute of Health and Care Excellence (NICE)

NeuWave Medical, Inc.

Orion Corporation

PhysioControl International, Inc.

Pinnacle Biologics Inc.

Sage Products, LLC

Stryker Corporation

Synergetics

Terumo Corporation

Unites States Food and Drug Administration (FDA)

ViaCyte, Inc.

W. L. Gore & Associates, Inc.

World Health Organization (WHO)

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com